US Patent Issued to WEST CHINA HOSPITAL, SICHUAN UNIVERSITY on April 22 for "Genetically engineered dual-targeting chimeric antigen receptor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,164, issued on April 22, was assigned to WEST CHINA HOSPITAL, SICHUAN UNIVERSITY (Sichuan, China).

"Genetically engineered dual-targeting chimeric antigen receptor and use thereof" was invented by Yongsheng Wang (Sichuan, China), Qizhi Ma (Sichuan, China), Dan Li (Sichuan, China) and Qiyu Yang (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of genetic engineering, and particularly relates to a genetically engineered dual-targeting chimeric antigen receptor. The present invention provides a genetically engineered dual-targeting chimeric antigen receptor and a host cell thereof in response to up...